^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersBIOMARKER:
BRCA2 mutation + AKR1C3 overexpression
i
Other names: BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset, AKR1C3, Aldo-Keto Reductase Family 1 Member C3, Prostaglandin F Synthase, Trans-1,2-Dihydrobenzene-1,2-Diol Dehydrogenase, 3-Alpha Hydroxysteroid Dehydrogenase, Type II, Testosterone 17-Beta-Dehydrogenase 5, Chlordecone Reductase Homolog HAKRb, Dihydrodiol Dehydrogenase X, Dihydrodiol Dehydrogenase 3, 3-Alpha-HSD Type II, Brain, Indanol Dehydrogenase, HSD17B5, HAKRB, Aldo-Keto Reductase Family 1, Member C3 (3-Alpha Hydroxysteroid Dehydrogenase, Type II), Type IIb 3-Alpha Hydroxysteroid Dehydrogenase, 17-Beta-Hydroxysteroid Dehydrogenase Type 5, 3-Alpha-Hydroxysteroid Dehydrogenase Type 2, Hydroxysteroid (17-Beta) Dehydrogenase 5, Dihydrodiol Dehydrogenase Type I, 3-Alpha-HSD Type 2, 17-Beta-HSD 5, DDH1
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related biomarkers:
›
